Pediatrix Medical Group - MD Stock Forecast, Price & News

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. As of February 17, 2022, it operated a network of approximately 2,700 physicians. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on MD shares. BMO Capital Markets cut their price target on shares of Pediatrix Medical Group from $25.00 to $23.00 and set a "market perform" rating on the stock in a report on Wednesday. Mizuho reduced their price objective on shares of Pediatrix Medical Group from $28.00 to $23.00 in a research note on Monday, May 2nd. Deutsche Bank Aktiengesellschaft decreased their price objective on Pediatrix Medical Group from $24.00 to $16.00 in a report on Tuesday, May 10th. StockNews.com lowered shares of Pediatrix Medical Group from a "buy" rating to a "hold" rating in a research note on Monday, May 2nd. Finally, Credit Suisse Group reduced their target price on shares of Pediatrix Medical Group from $30.00 to $28.00 and set an "outperform" rating on the stock in a research report on Thursday. Four analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $24.67.

Pediatrix Medical Group Trading Up 0.9 %

Shares of Pediatrix Medical Group stock traded up $0.19 during mid-day trading on Friday, hitting $21.23. The stock had a trading volume of 373,377 shares, compared to its average volume of 829,154. Pediatrix Medical Group has a 12-month low of $17.17 and a 12-month high of $35.67. The company has a quick ratio of 1.39, a current ratio of 1.39 and a debt-to-equity ratio of 0.94. The firm has a market cap of $1.79 billion, a P/E ratio of 21.66, a price-to-earnings-growth ratio of 1.33 and a beta of 1.84. The firm has a 50-day moving average of $21.42 and a two-hundred day moving average of $21.98.

Pediatrix Medical Group (NYSE:MD - Get Rating) last released its earnings results on Thursday, August 4th. The company reported $0.47 EPS for the quarter, topping the consensus estimate of $0.43 by $0.04. Pediatrix Medical Group had a return on equity of 16.15% and a net margin of 4.30%. The firm had revenue of $486.00 million during the quarter, compared to analysts' expectations of $491.54 million. During the same period in the previous year, the firm posted $0.36 EPS. Pediatrix Medical Group's revenue for the quarter was up 2.7% on a year-over-year basis. Sell-side analysts forecast that Pediatrix Medical Group will post 1.69 earnings per share for the current year.